Can a patient with impaired renal function (IRF) undergoing dialysis take nitrofurantoin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin Use in Dialysis Patients

Nitrofurantoin should not be used in patients on dialysis due to the risk of toxic metabolite accumulation that can cause peripheral neuropathy and other serious adverse effects. 1

Contraindications in Renal Impairment

  • Nitrofurantoin is contraindicated in patients with severe renal impairment (creatinine clearance < 30 mL/min) and should be avoided entirely in dialysis patients 2
  • The drug can produce toxic metabolites which cause peripheral neuropathy, particularly in patients with renal insufficiency 1
  • Nephrotoxic drugs should be avoided entirely in patients with chronic kidney disease (CKD) undergoing dialysis 1

Mechanism of Concern

  • Nitrofurantoin and its metabolites are primarily cleared by the kidneys, and impaired renal function significantly alters the drug's:
    • Volume of distribution
    • Metabolism
    • Rate of elimination
    • Bioavailability 1
  • In dialysis patients, these alterations lead to:
    • Accumulation of the drug and its toxic metabolites
    • Increased risk of adverse effects
    • Potentially decreased efficacy 2

Specific Risks in Dialysis Patients

Neurological Complications

  • Peripheral neuropathy, which may become severe or irreversible, is a significant risk 2
  • Conditions such as renal impairment (particularly with creatinine clearance under 60 mL/min) enhance the occurrence of peripheral neuropathy 2
  • Optic neuritis has also been reported with nitrofurantoin use 2

Pulmonary Reactions

  • Acute, subacute, or chronic pulmonary reactions can occur with nitrofurantoin use 2
  • These reactions can be severe and have been cited as contributing causes of death 2
  • Patients with renal impairment are at higher risk for developing these complications 3

Hepatic Reactions

  • Hepatic reactions including hepatitis, cholestatic jaundice, chronic active hepatitis, and hepatic necrosis can occur 2
  • These reactions are rare but can be fatal 2

Alternative Antibiotic Options for Dialysis Patients

  • For patients allergic to penicillin, clindamycin is recommended as the drug of choice for prophylaxis in dialysis patients 1
  • For treatment of urinary tract infections in dialysis patients, consider:
    • Amoxicillin (with appropriate dose adjustment)
    • Cephalexin (for penicillin-allergic patients)
    • Trimethoprim-sulfamethoxazole (with caution in severe renal insufficiency) 1

Antibiotic Dosing Considerations in Dialysis

  • Many antibiotics require dosage adjustments in dialysis patients 1
  • General principles for antibiotic use in dialysis:
    • Increasing dosing intervals rather than decreasing doses is often preferred 1
    • Antibiotics should generally be administered after hemodialysis to avoid drug removal during dialysis 1
    • Consultation with a nephrologist is recommended before prescribing antibiotics to dialysis patients 1

Common Pitfalls and Caveats

  • Some clinicians may consider using nitrofurantoin in patients with moderate renal impairment (CrCl 30-60 mL/min) based on limited evidence 4, 5, but this approach is not recommended for dialysis patients
  • Even in patients with normal renal function, nitrofurantoin can cause serious adverse effects, and the recommended dosage and duration should not be exceeded 6
  • Treatment failure rates are higher when nitrofurantoin is used in patients with reduced renal function 7
  • The risk of pulmonary toxicity from nitrofurantoin can mimic severe sepsis with elevated inflammatory markers, making diagnosis challenging 3

In conclusion, nitrofurantoin should be avoided in patients on dialysis due to the significant risks of toxicity and the availability of safer alternative antibiotics.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017

Research

Nitrofurantoin polyneuropathy: report of two cases.

American journal of hospital pharmacy, 1977

Research

Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.